Section of Rhinology, Sinus and Skull Base Surgery, Head & Neck Institute,, Cleveland Clinic Foundation, Cleveland, OH.
Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD.
Int Forum Allergy Rhinol. 2018 Oct;8(10):1098-1106. doi: 10.1002/alr.22174. Epub 2018 Jul 6.
Evidence suggests relationships between allergic rhinitis (AR) and poor sleep parameters, but population-based studies in the United States are lacking. This study investigates the relationship between AR and sleep parameters in a representative sample of U.S. adults.
Cross-sectional study of 5563 participants ≥18 years old from the 2005-2006 National Health and Nutrition Examination Survey who participated in the allergy and sleep questionnaires. The predictor variable was AR (self-reported hay fever and/or nasal symptoms in the past 12 months). The outcome variables were individual sleep parameters (sleep latency, sleep duration, sleep disorders, sleep habits, sleep medication use, daytime dysfunction). Covariates included age, gender, race, and obesity.
The population-weighted prevalence of AR was 36.5%. Adjusting for covariates, subjects with AR had higher odds of sleep latency ≥30 minutes (OR 1.24; 95% CI, 1.01 to 1.51; p = 0.04), sleep apnea (OR 1.86; 95% CI, 1.22 to 2.82; p < 0.01), insomnia (OR 1.85; 95% CI, 1.04 to 3.32; p = 0.04), trouble falling asleep (OR 1.43; 95% CI, 1.17 to 1.75; p < 0.01), waking up during the night (OR 1.49; 95% CI, 1.11 to 1.99; p = 0.01), waking up too early in the morning (OR 1.46; 95% CI, 1.20 to 1.79; p < 0.01), feeling unrested during the day (OR 1.76, 95% CI, 1.43 to 2.16; p < 0.01), feeling overly sleeping during the day (OR 1.54; 95% CI, 1.25 to 1.90; p < 0.01), not getting enough sleep (OR 1.68; 95% CI, 1.41 to 1.99; p < 0.01), using sleep medication (OR 1.69; 95% CI, 1.23 to 2.33; p < 0.01), difficulty concentrating (OR 1.93; 95% CI, 1.30 to 2.88; p < 0.01), remembering (OR 1.91; 95% CI, 1.22 to 2.97; p < 0.01), managing finances (OR 1.68; 95% CI, 1.09 to 2.56; p = 0.02), working (OR 2.16; 95% CI, 1.45 to 3.22; p < 0.01), and getting things done (OR 2.35; 95% CI, 1.36 to 4.06; p < 0.01) due to daytime sleepiness.
This analysis of a representative sample of U.S. adults revealed associations between AR and poor sleep parameters including prolonged sleep latency, insomnia, sleep apnea, sleep disturbances, sleep medication use, and daytime dysfunction. These findings reinforce the need to assess sleep quality in patients undergoing evaluation for AR.
有证据表明过敏性鼻炎(AR)与较差的睡眠参数之间存在关联,但美国缺乏基于人群的研究。本研究调查了美国代表性成年人样本中 AR 与睡眠参数之间的关系。
对参加过敏和睡眠问卷调查的 5563 名年龄≥18 岁的 2005-2006 年全国健康和营养调查参与者进行横断面研究。预测变量为 AR(过去 12 个月内有干草热和/或鼻部症状的自我报告)。因变量为个体睡眠参数(入睡潜伏期、睡眠持续时间、睡眠障碍、睡眠习惯、睡眠药物使用、日间功能障碍)。协变量包括年龄、性别、种族和肥胖。
人群加权的 AR 患病率为 36.5%。在调整协变量后,患有 AR 的受试者入睡潜伏期≥30 分钟的可能性更高(比值比 1.24;95%置信区间,1.01 至 1.51;p = 0.04)、患有睡眠呼吸暂停(比值比 1.86;95%置信区间,1.22 至 2.82;p < 0.01)、患有失眠(比值比 1.85;95%置信区间,1.04 至 3.32;p = 0.04)、入睡困难(比值比 1.43;95%置信区间,1.17 至 1.75;p < 0.01)、夜间醒来(比值比 1.49;95%置信区间,1.11 至 1.99;p = 0.01)、清晨过早醒来(比值比 1.46;95%置信区间,1.20 至 1.79;p < 0.01)、白天感到疲倦(比值比 1.76;95%置信区间,1.43 至 2.16;p < 0.01)、白天感到过度嗜睡(比值比 1.54;95%置信区间,1.25 至 1.90;p < 0.01)、睡眠不足(比值比 1.68;95%置信区间,1.41 至 1.99;p < 0.01)、使用睡眠药物(比值比 1.69;95%置信区间,1.23 至 2.33;p < 0.01)、注意力不集中(比值比 1.93;95%置信区间,1.30 至 2.88;p < 0.01)、记忆力下降(比值比 1.91;95%置信区间,1.22 至 2.97;p < 0.01)、管理财务(比值比 1.68;95%置信区间,1.09 至 2.56;p = 0.02)、工作(比值比 2.16;95%置信区间,1.45 至 3.22;p < 0.01)和完成任务(比值比 2.35;95%置信区间,1.36 至 4.06;p < 0.01)的可能性增加,这些都是由于白天嗜睡。
本研究对美国代表性成年人样本进行了分析,发现 AR 与较差的睡眠参数之间存在关联,包括入睡潜伏期延长、失眠、睡眠呼吸暂停、睡眠障碍、睡眠药物使用和日间功能障碍。这些发现强调了在评估 AR 患者时评估睡眠质量的必要性。